We evaluated the HCC risk for each subgroup by estimating the ORs associated with the combined VEGF -2578 CA/AA variant genotypes compared with the VEGF -2578 CC genotypes, with adjustment for the aforementioned variables (Table 2). The gene discussed is VEGFA; the disease is hepatocellular carcinoma.